Global Research Ventures

Global Research Ventures (GRV) was founded in 2015 with a mission to provide industry leading genetics, cultivation, manufacturing and research for theadvancement of responsible and therapeutic cannabis use.Through the GRV Production Cycle, GRV produces pharmaceutical grade medicinal cannabis free of mold, pesticides or heavy metals. Unfortunately, lack of regulation leaves patients vulnerable to harmful chemical nutrients and foliar sprays. Our strict standards and cultivation best practices ensures our cultivars to grow in favorable conditions that produce a clean, high quality product, with a high yield. Our environmentally friendly techniques enable us to reclaim water and reduce waste. GRV is committed to economic, social and environmental sustainability throughout every level of our work.

In 2016 Global Research Ventures was awarded a coveted medical marijuana cultivation license in Adelanto, California, to produce pharmaceutical grade medicinal cannabis. GRV purchased 3.5 acres of land and is erecting a 60,000 sq feet facility to house GRV’s operations, breeding program, cultivations, laboratory and office space. In a city where 62% of residents are receiving public assistance and living at or below the poverty line, GRV aims to revitalize Adelanto’s economy through its work. Phase one of the project will provide 25-30 new jobs, and upon completion of Phases 2 and 3, over 100 new jobs will be created in the City of Adelanto. GRV’s total investment will be upwards of $6MM in Adelanto.